false 0001479681 0001479681 2024-07-24 2024-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

   

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 24, 2024

 

NUTEX HEALTH INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41346   11-3363609
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

6030 S. Rice Ave, Suite C, Houston, Texas 77081

(Address of principal executive offices) (zip code)

 

(713) 660-0557

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001   NUTX   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 
 

Item 8.01 Other Events.

 

On July 24, 2024, Nutex Health Inc. (the “Company”) received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), as required by the Hearing Panel’s June 14, 2024 decision, which was previously disclosed in the Company’s Current Report on Form 8-K filed on June 18, 2024.

Nasdaq notified the Company in the Compliance Notice that, from July 3, 2024, the date of the Company’s 1:10 reverse stock split, to July 23, 2024, the closing bid price of the Company’s common stock had traded above $1.00 per share and, accordingly, the Staff of Nasdaq determined that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, the Hearing Panel determined to continue the listing of the Company’s common stock on The Nasdaq Stock Market and closed this matter.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

Exhibit No. Description of Exhibit
   
104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated:  July 25, 2024 NUTEX HEALTH INC.
   
  By: /s/ Jon C. Bates
    Jon C. Bates
Chief Financial Officer

 

v3.24.2
Cover
Jul. 24, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 24, 2024
Entity File Number 001-41346
Entity Registrant Name NUTEX HEALTH INC.
Entity Central Index Key 0001479681
Entity Tax Identification Number 11-3363609
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 6030 S. Rice Ave
Entity Address, Address Line Two Suite C
Entity Address, City or Town Houston
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77081
City Area Code 713
Local Phone Number 660-0557
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol NUTX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Grafico Azioni Nutex Health (NASDAQ:NUTX)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Nutex Health
Grafico Azioni Nutex Health (NASDAQ:NUTX)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Nutex Health